How GLP-1 medication impact appetite and metabolism

Could there be a different approach to weight loss? Many of us have spent years battling our weight, trying every fad diet and fitness trend with little success. We know the frustration of restrictive eating, the exhaustion of intense workouts, and the disappointment of seeing the numbers on the scale creep back up. What if there was a way to break free from this cycle, to achieve sustainable weight loss without the constant struggle?

For many women in the UK losing weight feels like an endless cycle of failed attempts. But what if there was a solution that actually worked with your body’s natural processes? GLP-1 medications, such as Wegovy and Mounjaro, have emerged as a powerful tool in the fight against obesity, offering new hope for long-term weight loss and improved metabolic health. These medications don’t just suppress hunger—they actively help the body regulate blood sugar and fat storage, addressing the root causes of weight gain. 

Understanding how these medications can complement dietary changes, exercise, and lifestyle modifications for effective weight management will help you make an informed decision. Whether you’re struggling with weight loss or simply exploring new options, this blog will help you understand the potential of GLP-1 agonists to change your weight management journey for good.

Understanding GLP-1 Hormones

To truly appreciate how GLP-1 medications like Wegovy and Mounjaro work, it’s important to first understand GLP-1 hormones and their role in the body. GLP-1 is a peptide hormone secreted by cells in the small intestine after you eat. It has a few crucial roles:

• Regulating blood sugar levels: GLP-1 helps the pancreas release insulin (the hormone responsible for lowering blood sugar) in response to food, especially after a meal. It also inhibits the release of glucagon, a hormone that raises blood sugar levels. This twofold effect helps maintain stable blood sugar levels.
• Appetite control: GLP-1 also acts on the brain, particularly the hypothalamus, to help you feel full after eating. It enhances the sensation of satiety, which in turn reduces the urge to eat.
• Slows down gastric emptying: In addition to these functions, GLP-1 also slows down the process of gastric emptying (the rate at which food leaves the stomach), which further contributes to feeling full for longer.

How GLP-1 Medications Work

GLP-1 medications, such as semaglutide and tirzepatide, are synthetic versions of the natural GLP-1 hormone. These medications work by mimicking the effects of GLP-1, but with enhanced potency and a longer duration of action. They help regulate both appetite and blood sugar levels.

The Impact of GLP-1 Medications on Appetite

One of the most powerful effects of GLP-1 medications is their ability to regulate appetite—something that has long been a struggle for those dealing with obesity or uncontrolled hunger. But how exactly do these medications influence appetite, and what makes them so effective in controlling food intake?

1. Appetite Regulation:

GLP-1 medications help regulate appetite by influencing several key appetite hormones. When you take these medications, they mimic the action of the natural GLP-1 hormone, which plays a crucial role in hunger regulation. Specifically, GLP-1 increases the release of hormones that signal to the brain that you are full, while decreasing the release of hunger hormones like ghrelin. As a result, hunger is reduced, and the drive to eat decreases significantly.

The Role of the Brain-Gut Axis in Appetite Control:

The connection between the gut and the brain, known as the brain-gut axis, is central to appetite regulation. GLP-1 medications work through this axis by signalling the brain to stop feeling hungry, especially after eating. The medication slows gastric emptying, meaning food stays in the stomach longer, contributing to longer-lasting feelings of fullness. Simultaneously, it reduces the desire to eat more, even when food is readily available.

This dual effect—delaying the feeling of hunger while promoting satiety—is one reason GLP-1 medications have been so effective for individuals who struggle with emotional eating, binge eating, or those who have a dysregulated appetite. In clinical studies, people on GLP-1 medications have reported fewer cravings and a greater ability to control their eating habits, especially when compared to those taking placebos or other weight loss treatments.

2. Satiety and Fullness:

GLP-1 medications also work by increasing satiety—the feeling of fullness after eating. This is achieved through a combination of slowing gastric emptying and enhancing the signals that tell your brain you've had enough to eat. By prolonging feelings of fullness, these medications help individuals naturally reduce their calorie intake without the need for restrictive dieting or constant willpower.

In addition to controlling hunger, GLP-1 medications have a positive impact on food cravings and binge eating. Since these medications regulate appetite and improve the body's ability to stay satisfied after meals, they can significantly reduce the likelihood of overeating, which is often triggered by cravings or emotional cues. This effect makes GLP-1 treatments especially valuable for people who struggle with impulsive eating or emotional triggers that lead to overeating.

The Impact of GLP-1 Medications on Metabolism

Beyond appetite control, GLP-1 medications have profound effects on metabolism, making them not only effective for weight loss but also for improving metabolic health. These medications help the body use insulin more efficiently, regulate blood sugar, and even affect energy expenditure. The impact on metabolism is one of the reasons they are so effective for those with type 2 diabetes or pre-diabetes as well as for those looking to lose weight and improve overall health.

1. Metabolic Benefits:

One of the key metabolic benefits of GLP-1 medications is their ability to improve insulin sensitivity. Insulin is a hormone that helps the body store and use sugar from food. In individuals with obesity or type 2 diabetes, the body’s cells become less responsive to insulin, leading to higher blood sugar levels. GLP-1 medications, like Mounjaro and Wegovy, help restore insulin sensitivity by enhancing insulin release when blood sugar levels are elevated and inhibiting glucagon, a hormone that increases blood sugar.

As a result, blood sugar levels are better controlled, leading to improvements in metabolic health and a reduction in the risk of developing complications from type 2 diabetes, such as heart disease, kidney problems, or nerve damage. This insulin-sensitising effect is one of the key reasons these medications are used for both obesity management and diabetes control.

2. The Potential for Weight Loss and Reduced Risk of Type 2 Diabetes

The insulin-sensitising effect of GLP-1 medications also supports weight loss by encouraging the body to burn stored fat more effectively. Since insulin resistance is often associated with increased fat storage, improving insulin sensitivity helps reduce this fat storage, leading to sustained weight loss. In fact, several clinical trials have shown that people using GLP-1 medications have experienced weight reductions of up to 15% or more of their body weight, which is a significant improvement compared to other weight loss interventions.

Additionally, by improving insulin sensitivity and controlling blood sugar, GLP-1 medications reduce the risk of developing type 2 diabetes in individuals who are pre-diabetic or have a higher risk due to obesity. This dual action—helping with both weight loss and blood sugar control—makes these medications a powerful tool in managing both obesity and metabolic diseases like diabetes.

3. Energy Expenditure:

While most people associate weight loss with a decrease in calorie intake, GLP-1 medications also influence energy expenditure, or the number of calories the body burns at rest. Studies suggest that GLP-1 medications may have a positive impact on the resting metabolic rate (RMR), meaning the body burns more calories even when not physically active.

In addition, by improving metabolic efficiency and promoting weight loss, GLP-1 medications may increase physical activity levels in some individuals. As people lose weight and feel better overall, they often experience an increase in energy and are more likely to engage in physical activities like walking, exercise, or other forms of movement. This increase in physical activity, combined with the appetite-suppressing effects of the medication, can further accelerate weight loss and improve cardiovascular and muscular health.

Safety and Side Effects of GLP-1 Medications

While GLP-1 medications like Mounjaro and Wegovy have proven to be effective in promoting weight loss and improving metabolic health, it’s essential to understand their potential side effects and long-term safety. Like any medication, these drugs come with the possibility of adverse reactions. However, most side effects are temporary and manageable, especially when patients follow dosing schedules and monitor their response with their healthcare provider.

Common Side Effects:

The most common side effects of GLP-1 medications are related to the gastrointestinal (GI) system. These can occur as the body adjusts to the medication’s effects on the stomach and digestive tract. The most frequently reported GI symptoms include:

• Nausea: This is the most common side effect, especially when starting the medication. It usually improves over time as the body becomes accustomed to the treatment.
• Vomiting: Along with nausea, some individuals may experience vomiting, particularly in the initial stages of treatment.
• Diarrhoea: Some people may experience loose stools or diarrhoea, especially as the stomach empties more slowly due to the medication’s effect.

While these GI symptoms can be unpleasant, they are generally temporary and tend to resolve within the first few weeks of treatment as the body adjusts. In clinical studies, the severity of side effects typically decreases after the initial dose adjustments, and many people find that they can tolerate the medication better over time.

Other non-GI side effects, though less common, may also occur. These include:

• Headache: A mild headache can occur as your body adjusts to the medication.
• Fatigue: Some people report feeling more tired than usual, especially during the first few weeks of treatment. This side effect is often temporary.
• Dizziness: This may occur, particularly if blood sugar levels fluctuate during the early stages of treatment.

These side effects are generally mild and often lessen or resolve after a few days or weeks. In most cases, they do not cause individuals to stop the medication. However, if these symptoms become persistent or severe, it’s important to consult with a healthcare provider to adjust the dose or explore alternative treatment options.

Long-Term Safety of GLP-1 Medications:

When it comes to long-term use, the safety profile of GLP-1 medications is still being studied, but clinical trials and real-world data suggest that they are generally safe when used as prescribed. In fact, many individuals benefit from using these medications for extended periods, particularly as part of a comprehensive weight management program that includes diet and exercise.

• Cardiovascular Health: GLP-1 medications like semaglutide (Wegovy) have been shown to have cardioprotective effects—reducing the risk of heart attack, stroke, and other cardiovascular events in people with obesity or type 2 diabetes. This is especially important, given that people with obesity are at higher risk of cardiovascular disease.
• Kidney Health: Some studies have shown that GLP-1 medications may also have protective effects on kidney function, particularly for those with type 2 diabetes. By improving insulin sensitivity and controlling blood sugar, these drugs can reduce the risk of kidney disease.
• Endocrine Concerns: There have been some concerns about the potential impact of GLP-1 medications on the thyroid, specifically a rare risk of thyroid cancer. In animal studies, certain GLP-1 drugs have been shown to cause thyroid tumours, but human studies have not conclusively linked GLP-1 use to thyroid cancer. As a result, the FDA has issued warnings, advising that GLP-1 medications should be used with caution in individuals with a family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2.

Monitoring for Potential Side Effects:

Although GLP-1 medications are generally well-tolerated, it is important to regularly monitor for potential side effects, especially in the early stages of treatment. Healthcare providers typically recommend regular check-ins to assess the medication’s effectiveness and manage any side effects. These check-ins may include:

• Monitoring gastrointestinal symptoms: If nausea, vomiting, or diarrhoea becomes severe or persistent, adjustments to the dose or a switch to a different medication may be necessary.
• Blood sugar levels: For individuals with type 2 diabetes, it’s essential to monitor blood sugar levels, as GLP-1 medications can lower blood sugar. This is particularly important if the person is also taking other diabetes medications, such as insulin or sulfonylureas, which may cause an increased risk of hypoglycemia (low blood sugar).
• Thyroid function: Although rare, patients should be aware of potential thyroid-related issues, and a healthcare provider may periodically assess thyroid function if there are any concerns.

It is also important for patients to inform their healthcare provider about any pre-existing conditions, including pancreatitis, gastrointestinal issues, or history of thyroid disease, as these may influence whether GLP-1 medications are suitable for them.

Considerations for Weight Loss

Maximising the Benefits of GLP-1 Medications

While GLP-1 medications like Wegovy and Mounjaro are powerful tools in the fight against obesity and metabolic health issues, they are most effective when used as part of a comprehensive weight loss strategy that includes healthy lifestyle changes. It's essential to understand that while these medications can significantly help control appetite and regulate metabolism, they work best when combined with dietary improvements,regular physical activity, and sometimes behavioural therapy.

Lifestyle Factors: The Importance of Combining GLP-1 Medications with a Healthy Diet and Regular Exercise

One of the key aspects of using GLP-1 medications for weight loss is that they should be viewed as part of a holistic approach to managing weight. These medications can make it easier to eat less, feel full, and control blood sugar, but they don’t do all the work on their own. The foundation of successful, sustainable weight loss still lies in diet and exercise.

• Healthy Diet: While GLP-1 medications help regulate appetite, they don't eliminate the need for a balanced, nutritious diet. In fact, pairing the medication with a diet focused on whole foods—rich in fruits, vegetables, lean proteins, and whole grainscan further optimise results. Eating smaller, nutrient-dense meals throughout the day can help prevent cravings and keep blood sugar levels stable, which is essential for weight loss and overall health.
• Regular Exercise: Regular physical activity, including aerobic exercise (like walking, cycling, or swimming) and strength training, plays a critical role in maintaining weight loss and improving overall metabolism. GLP-1 medications may also help by providing more energy and reducing fatigue, which may make it easier to increase activity levels and stick with a fitness routine.

Together, diet and exercise create a synergistic effect with GLP-1 medications, leading to more significant and sustainable weight loss outcomes. This combination can help address the root causes of obesity and metabolic dysfunction, rather than just treating the symptoms.

The Role of Behavioural Therapy in Weight Management

In addition to diet and exercise, behavioural therapy can be an important component of a successful weight management plan. The psychological and emotional aspects of eating—such as stress eating, emotional triggers, or poor eating habitscan significantly impact weight loss progress.

Behavioural therapy, whether through cognitive-behavioural therapy (CBT) or other forms of counselling, helps individuals identify emotional eating patterns, develop healthier coping strategies, and adopt long-term habits for maintaining weight loss. It can also help individuals set realistic goals, stay motivated, and improve self-esteem during the weight loss process.

Some people may benefit from group therapy or support groups that provide accountability and encouragement, while others may find that one-on-one counselling with a psychologist or therapist is more helpful. The combined support of medication, dietary changes, and behavioural interventions offers a more holistic and lasting solution to managing weight.

Choosing the Right Medication: Factors to Consider When Selecting a GLP-1 Medication

When considering GLP-1 medications for weight loss, it’s important to recognise that there is no one-size-fits-all solution. Factors such as personal health conditions, weight loss goals, and lifestyle preferences will all play a role in determining which medication is best for you.

Some of the key factors to consider when selecting a GLP-1 medication include:

• Effectiveness: Different GLP-1 medications vary in potency and may lead to different levels of weight loss. For example, Mounjaro (tirzepatide), which targets both GLP-1 and GIP (gastric inhibitory polypeptide) receptors, may offer enhanced weight loss compared to other GLP-1 medications like Wegovy (semaglutide). A healthcare provider will consider your weight loss goals and medical history to determine which medication may be most effective for you.
• Side Effect Tolerance: Some people may tolerate one medication better than another. For example, nausea is a common side effect of Wegovy, particularly during the initial weeks of treatment. If gastrointestinal symptoms are a concern, your doctor may recommend Mounjaro, which may have a different side effect profile.
• Comorbidities: If you have type 2 diabetes, your doctor may opt for a dual-action medication like Mounjaro, which helps manage both blood sugar and weight loss. For individuals without diabetes, Wegovy may be the preferred option, as it specifically targets appetite suppression and satiety.

The Role of a Healthcare Professional in Determining the Best Treatment Plan

Working closely with a healthcare professional is essential when considering GLP-1 medications for weight loss. A doctor will evaluate your overall health, consider any comorbid conditions (such as type 2 diabetes or hypertension), and review your medical history to determine whether GLP-1 medications are appropriate for you.

Your healthcare provider will also guide you through the process of titrating the medication (starting with a low dose and gradually increasing it), monitor for side effects, and help you adjust the dosage if needed. It’s also important to have open and ongoing communication about your weight loss progress, diet, exercise routine, and psychological support, to ensure that you’re seeing the best possible results.

In summary, GLP-1 medications can be an incredibly effective tool for weight loss, but they are most beneficial when used in conjunction with healthy lifestyle changessuch as a balanced diet, regular physical activity, and behavioural support. The combination of these factors can help you not only lose weight but also maintain those changes for the long term. Working with a healthcare professional to select the right medication and create a personalised treatment plan is key to achieving sustainable, meaningful results

‍

Conclusion

‍GLP-1 medications, such as Wegovy and Mounjaro, have emerged as groundbreaking treatments in the fight against obesity and metabolic health issues. These medications help regulate appetite, increase satiety, and improve insulin sensitivity, all of which can support sustainable weight loss.

While GLP-1 medications offer significant potential for weight loss and metabolic health, they are most effective when used as part of a holistic approach. The combination of healthy eating, regular physical activity, and behavioural therapy ensures long-term success, as medication alone is unlikely to lead to sustainable change without lifestyle adjustments.

If you’re considering GLP-1 treatment, it’s essential to consult with a healthcare professional who can assess your individual needs, discuss your health goals, and help determine the best course of action. A doctor will help you navigate the various treatment options and create a tailored plan that fits your specific circumstances.

In the journey towards better health and weight management, remember that no single solution works for everyone. Achieving lasting weight loss is a multifaceted process, and by combining medication with lifestyle changes and personalised support, you can achieve your goals and improve your overall well-being.

References

1. Department of Health and Social Care. (2024, May). Obesity Profile: Short statistical commentary. GOV.UK. https://www.gov.uk/government/statistics/obesity-profile-may-2024
2. Drucker, D. J. (2020). Glucagon-like peptide 1 (GLP-1). PubMed. https://pubmed.ncbi.nlm.nih.gov/33767808/
3. Frias, J. P., Davies, M. J., Rosenstock, J., Perez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., & Brown, K. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. https://pubmed.ncbi.nlm.nih.gov/34942372/
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384, 989–1002. https://pubmed.ncbi.nlm.nih.gov/35658024/
5. Garvey, W. T., Birkenfeld, A. L., Dicker, D., Mingrone, G., Pedersen, S. D., Satylganova, A., Skovgaard, D., & McGowan, B. M. (2024). Efficacy of semaglutide in subjects with obesity and prediabetes: Sustained effects after 2 years of treatment. Journal of Clinical Endocrinology & Metabolism, 109(4), 1234–1246. https://pmc.ncbi.nlm.nih.gov/articles/PMC10341852/
6. Marso, S. P., et al. (2016). "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes." The New England Journal of Medicine, 375(4), 311-322. This study found that liraglutide reduced the risk of major adverse cardiovascular events in patients with type 2 diabetes.
   New England Journal of Medicine
7. Marso, S. P., et al. (2016). "Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes." The New England Journal of Medicine, 375(19), 1834-1844. The trial demonstrated that semaglutide significantly lowered the risk of cardiovascular events compared to placebo.
   New England Journal of Medicine
8. Tuttle, K. R., et al. (2019). "Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials." Diabetes Care, 46(4), 801-810. This analysis indicated that semaglutide improved albuminuria and preserved kidney function in individuals with overweight or obesity, with or without type 2 diabetes.
   Diabetes Journals
9. Mann, J. F. E., et al. (2017). "Liraglutide and Renal Outcomes in Type 2 Diabetes." The New England Journal of Medicine, 377(9), 839-848. The study reported that liraglutide reduced the progression of renal disease in patients with type 2 diabetes. New England Journal of Medicine